Shrinkage of Inoperable Adenomas in Cavernous Sinus With High-dose Octreotide
(1993) The Lancet — Vol. 342, n° 8866, p. 301 (1993)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 164.73 KB
Details
- Authors
- Affiliations
Citations
Donckier, J., Buysschaert, M., & Gilliard, C. (1993). Shrinkage of Inoperable Adenomas in Cavernous Sinus With High-dose Octreotide. The Lancet, 342(8866), 301. https://doi.org/10.1016/0140-6736(93)91845-D (Original work published 1993)